The renin-angiotensin system: A 21st century perspective

Journal of the American Society of Nephrology

Volumn 15, Issue 7, 2004, Pages 1963-1964

  Campbell, Ruth C ^a,b  

^a University of Alabama at Birmingham   (United States)

^b ZRB 604   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; ANTIINFLAMMATORY AGENT; CATHEPSIN D; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RENIN; TRANSFORMING GROWTH FACTOR BETA;

BIOSYNTHESIS; BLOOD PRESSURE REGULATION; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CYTOKINE PRODUCTION; DRUG EFFECT; EDITORIAL; EXPERIMENTAL MODEL; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; KIDNEY BLOOD FLOW; KIDNEY TUBULE ABSORPTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM ABSORPTION; TISSUE DISTRIBUTION; UPREGULATION; VASOCONSTRICTION;

EID: 3042584644     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000133013.36628.87     Document Type: Editorial

References (19)

1. Lansang M, Price D, Laffel L, Osei S, Fisher N, Erani D, Hollenberg N: Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. Kidney Int 59: 1432-1438, 2001
2. Price D, Fisher N, Osei S, Lansang M, Hollenberg N: Renal perfusion and function in healthy African Americans. Kidney Int 59: 1037-1043, 2001
3. Navar L: The intrarenal renin-angiotenisn system in hypertension. Kidney Int 65: 1522-1532, 2004
4. Navar L, Harrison-Bernard L, Nishiyama A, Kobori H: Regulation of intrarenal angiotensin II in hypertension. Hypertension 39: 316-322, 2002
5. Navar L, Inscho E, Majid S, Imig J, Harrison-Bernard L, Mitchell K: Paracrine regulation of the renal microcirculation. Physiol Rev 1996: 425-536, 1996
6. Siragy H: AT1 and AT2 Receptor in the kidney: role in health and disease. Semin Nephrol 24: 93-100, 2004
7. Nishiyama A, Seth D, Navar L: Renal interstitial concentrations of angiotensins I and II in anesthesized rats. Hypertension 39: 129-134, 2002
8. Kobori H, Nishiyama A, Abe Y, Navar L: Enhancement of intrarenal angiotensinogen in Dahl salt-sensitve rats on high salt diet. Hypertension 41: 529-597, 2003
9. Kobori H, Prieto-Carrasquero M, Ozawa Y, Navar L: AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 43: 1126-1132, 2004
10. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J: Inflammation and angiotensin II. Int J Biochem Cell Biol 35: 881-900, 2003
11. Agarwal R, Campbell R, Warnock D: Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Semin Nephrol 24: 101-114, 2004
12. Jaimes E, Galceran J, Raij L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54: 775-784, 1998
13. Rodriguez-Iturbe B, Vaziri N, Herrera-Acosta J, Johnson R: Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286: F606-F616, 2004
14. Tapia E, Franco M, Sanchez-Lozada L, Soto V, Avila-Casado C, Santamaria J, Auiroz Y, Rodreiguez-Itrube B, Herrera-Acosta J: Mycophenolate mofetil prevents arteriopathy and renal injury in subtotal ablation depsite persistent hypertension. Kidney Int 63: 994-1002, 2003
15. Quiroz Y, Pons H, Gordon KL, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, Johnson R, Rodriguez-Iturbe B: Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 281: F38-F47, 2001
16. Fujihara C, Malheiros D, Noronha I, Nucci GD, Zatz R: Mycophenolate mofetil reduces renal injury in the chronic nitric oxide synthase inhibition model. Hypertension 37: 170-175, 2001
17. Graciano ML, de Cassia Cavaglieri R, Dellê H, Dominguez WV, Casarini DE, Avancini Costa Malheiros DM, Noronha IL: Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15: 1805-1815, 2004
18. Morris B, Reid I: A "renin-like" enzymatic action of cathepsin D and the similarity in subcellular distributions of "renin-like" activity and cathepsin D in the midbrain of dogs. Endocrinology 103: 1289-1296, 1978
19. Huang X, Chen W, Truong L, Lan H: Chymase is upregulated in diabetic nephropathy: Implications for an alternative pathways of angiotensin II mediated diabetic renal and vascular disease. JAMA 14: 1738-1747, 2003